title: Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis.
abstract: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) characterized by encephalitogenic leukocyte infiltration and multifocal plaques of demyelination. Patients present with debilitating clinical sequelae including motor, sensory, and cognitive deficits. For the past 30 years, immune modulating treatments have entered the marketplace and continue to improve in limiting the frequency and severity of relapses, but no cure has been found and no drug has successfully stopped chronic progressive disease. Recent work focusing on the oligodendrocyte, the myelin-producing cell, has provided needed insight into the process of demyelination, the spontaneous ability of the CNS to regenerate, and the inevitable failure of remyelination. From this a number of promising molecular targets have been identified to protect oligodendrocytes and promote remyelination. Combining immunomodulatory therapy with strategies to protect oligodendrocytes from further degeneration and enhance remyelination presents a very real means to improve clinical outcome for chronic progressive patients in the near future. Here we lay out a combination therapy approach to treating MS and survey the current literature on promising drug candidates potentially capable of mediating oligodendrocyte protection and enhancing remyelination.
authors.affiliation: Department of Microbiology-Immunology and Interdepartmental Immunobiology Center, Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave., Chicago, Illinois 60611, USA.
authors.forename: Jane M
authors.initials: JM
authors.lastname: Rodgers
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Robinson
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Miller
mesh_terms: D002490:Central Nervous System / Q000502:physiology*; D003711:Demyelinating Diseases; D006801:Humans; D056747:Immunomodulation / Q000187:drug effects*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009186:Myelin Sheath / Q000502:physiology*; D009836:Oligodendroglia / Q000502:physiology*; D012038:Regeneration
references.citation: Curr Atheroscler Rep. 2005 Feb;7(1):34-9
references.pmid: 15683600
references.citation: Nat Med. 2002 Oct;8(10):1115-21
references.pmid: 12357247
references.citation: Glia. 2002 Apr 15;38(2):155-68
references.pmid: 11948809
references.citation: Nat Biotechnol. 2013 May;31(5):434-9
references.pmid: 23584610
references.citation: Nat Protoc. 2009;4(11):1614-22
references.pmid: 19834476
references.citation: Brain. 2004 Sep;127(Pt 9):1928-41
references.pmid: 15289265
references.citation: Glia. 2002 Mar 1;37(3):241-9
references.pmid: 11857682
references.citation: Brain. 2011 Feb;134(Pt 2):571-84
references.pmid: 21233144
references.citation: PLoS One. 2013;8(2):e55149
references.pmid: 23383310
references.citation: Dermatology. 2010;220(4):370-5
references.pmid: 20484880
references.citation: Mult Scler. 2008 May;14(4):541-6
references.pmid: 18562508
references.citation: J Immunol. 2011 Sep 1;187(5):2405-17
references.pmid: 21821796
references.citation: Nat Med. 2007 Apr;13(4):492-7
references.pmid: 17401376
references.citation: J Neurosci. 2006 Jan 4;26(1):328-32
references.pmid: 16399703
references.citation: J Neurosci Res. 1999 Jul 15;57(2):236-43
references.pmid: 10398301
references.citation: Nat Methods. 2011 Sep 25;8(11):957-62
references.pmid: 21946668
references.citation: CNS Drugs. 2011 Mar;25(3):187-201
references.pmid: 21323391
references.citation: Glia. 2010 Dec;58(16):1913-27
references.pmid: 20878765
references.citation: Mol Cell Endocrinol. 2003 Jan 31;199(1-2):49-60
references.pmid: 12581879
references.citation: Stem Cells Dev. 2011 Feb;20(2):289-300
references.pmid: 20575640
references.citation: Int Immunol. 1996 Jan;8(1):131-41
references.pmid: 8671597
references.citation: Nat Biotechnol. 2013 May;31(5):426-33
references.pmid: 23584611
references.citation: Neuron. 1997 Jul;19(1):197-203
references.pmid: 9247275
references.citation: Glia. 2005 Jan 15;49(2):301-8
references.pmid: 15472992
references.citation: Neuroscience. 2012 Dec 13;226:40-50
references.pmid: 23000619
references.citation: Nat Neurosci. 2011 Jun 26;14(8):1009-16
references.pmid: 21706018
references.citation: Biochem J. 1977 May 15;164(2):323-9
references.pmid: 880240
references.citation: Lancet Neurol. 2012 Feb;11(2):150-6
references.pmid: 22236384
references.citation: Glia. 2010 Nov 15;58(15):1782-93
references.pmid: 20645409
references.citation: J Neuroimmunol. 2010 Jan 25;218(1-2):3-11
references.pmid: 19748685
references.citation: Nature. 2002 Nov 7;420(6911):78-84
references.pmid: 12422218
references.citation: Acta Neurol Scand Suppl. 2006;183:41-7
references.pmid: 16637928
references.citation: J Neuroimmunol. 2011 Jun;235(1-2):18-26
references.pmid: 21612829
references.citation: Nat Protoc. 2011 May;6(5):640-55
references.pmid: 21527921
references.citation: Ann Neurol. 2004 May;55(5):756
references.pmid: 15122721
references.citation: J Neuropathol Exp Neurol. 1997 Nov;56(11):1191-201
references.pmid: 9370229
references.citation: Glia. 2008 Aug 15;56(11):1238-49
references.pmid: 18452213
references.citation: PLoS One. 2008 Apr 09;3(4):e1928
references.pmid: 18398457
references.citation: Ann Neurol. 2009 Mar;65(3):304-15
references.pmid: 19334062
references.citation: Am J Cardiol. 1988 Nov 11;62(15):10J-15J
references.pmid: 3055919
references.citation: J Neurol Sci. 2008 Feb 15;265(1-2):105-10
references.pmid: 17706971
references.citation: Br J Pharmacol. 2011 Aug;163(7):1520-32
references.pmid: 21480865
references.citation: J Neurosci Res. 2004 Aug 1;77(3):367-77
references.pmid: 15248293
references.citation: J Neurosci Res. 2002 Sep 15;69(6):966-75
references.pmid: 12205690
references.citation: Exp Neurol. 2008 May;211(1):214-26
references.pmid: 18346732
references.citation: Neuroscience. 2011 Sep 29;192:588-97
references.pmid: 21736923
references.citation: Brain. 2008 Jul;131(Pt 7):1749-58
references.pmid: 18515322
references.citation: J Neurosci Res. 2007 Apr;85(5):967-76
references.pmid: 17304578
references.citation: Genes Dev. 2009 Jul 1;23(13):1571-85
references.pmid: 19515974
references.citation: Nature. 2003 Apr 17;422(6933):688-94
references.pmid: 12700753
references.citation: J Neuroimmunol. 2006 Feb;171(1-2):135-44
references.pmid: 16303184
references.citation: Nat Neurosci. 2009 Jul;12(7):829-38
references.pmid: 19503085
references.citation: J Neurosci. 2002 Nov 15;22(22):9742-53
references.pmid: 12427829
references.citation: Expert Rev Neurother. 2011 Apr;11(4):467-8
references.pmid: 21469916
references.citation: Neurology. 2012 Apr 10;78(15):1171-8
references.pmid: 22459680
references.citation: J Neurosci Res. 2005 Feb 1;79(3):340-50
references.pmid: 15605375
references.citation: BMJ. 2010 Mar 11;340:c1387
references.pmid: 20223864
references.citation: Antimicrob Agents Chemother. 1996 Apr;40(4):934-40
references.pmid: 8849255
references.citation: Glia. 2011 Jun;59(6):882-92
references.pmid: 21438010
references.citation: J Neuropathol Exp Neurol. 1993 May;52(3):199-204
references.pmid: 7684075
references.citation: J Neurol. 2008 Mar;255 Suppl 1:19-25
references.pmid: 18317673
references.citation: Arch Neurol. 2008 Aug;65(8):1031-8
references.pmid: 18695053
references.citation: Cell Stem Cell. 2013 Feb 7;12(2):252-64
references.pmid: 23395447
references.citation: Nat Med. 2007 Dec;13(12):1483-9
references.pmid: 17994101
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7583-8
references.pmid: 9207135
references.citation: J Neuroimmunol. 2005 Dec 30;170(1-2):3-10
references.pmid: 16290267
references.citation: Eur J Biochem. 1995 Aug 15;232(1):54-61
references.pmid: 7556170
references.citation: Mol Cell Neurosci. 2003 Dec;24(4):1074-82
references.pmid: 14697670
references.citation: Brain. 1999 Dec;122 ( Pt 12):2279-95
references.pmid: 10581222
references.citation: Exp Neurol. 2002 Sep;177(1):242-51
references.pmid: 12429226
references.citation: Nat Rev Neurosci. 2008 Nov;9(11):839-55
references.pmid: 18931697
references.citation: Exp Hematol. 1993 Dec;21(13):1628-39
references.pmid: 8243565
references.citation: J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):228-37
references.pmid: 17692515
references.citation: J Neurosci. 2011 Jan 19;31(3):1069-80
references.pmid: 21248132
references.citation: Mol Cell Neurosci. 2009 Nov;42(3):255-65
references.pmid: 19619658
references.citation: Med Clin North Am. 1995 Jul;79(4):789-801
references.pmid: 7791423
references.citation: J Neurosci. 1998 Oct 1;18(19):7700-8
references.pmid: 9742140
references.citation: Drugs Today (Barc). 2004 Aug;40(8):663-76
references.pmid: 15510238
references.citation: Expert Opin Biol Ther. 2008 Oct;8(10):1561-70
references.pmid: 18774923
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6820-5
references.pmid: 10841576
references.citation: Neurosci Lett. 2009 Mar 27;453(1):73-6
references.pmid: 19429019
references.citation: J Neuroimmunol. 2008 Jan;193(1-2):120-9
references.pmid: 18037503
references.citation: Mt Sinai J Med. 2011 Mar-Apr;78(2):161-75
references.pmid: 21425262
references.citation: Ann Neurol. 1993 Feb;33(2):137-51
references.pmid: 8434875
references.citation: Cell Stem Cell. 2008 Jun 5;2(6):553-65
references.pmid: 18522848
references.citation: Int J Biochem Cell Biol. 2008;40(10):1971-8
references.pmid: 18468478
references.citation: Mult Scler. 2009 Oct;15(10):1183-94
references.pmid: 19776092
references.citation: Behav Brain Res. 2009 Jan 23;196(2):168-79
references.pmid: 18977395
references.citation: Nat Biotechnol. 2012 Dec;30(12):1217-24
references.pmid: 23159881
references.citation: Am J Pathol. 2000 Jul;157(1):267-76
references.pmid: 10880396
references.citation: J Neuroimmunol. 2008 Jul 15;197(2):140-6
references.pmid: 18555539
references.citation: CNS Drugs. 2011 May;25(5):401-14
references.pmid: 21476611
references.citation: Clin Neurol Neurosurg. 2006 Mar;108(3):266-70
references.pmid: 16413965
references.citation: Sci Transl Med. 2013 Jun 5;5(188):188ra75
references.pmid: 23740901
references.citation: Nat Methods. 2005 May;2(5):333-6
references.pmid: 15846359
references.citation: Brain. 2002 Jun;125(Pt 6):1297-308
references.pmid: 12023318
references.citation: Nat Rev Neurosci. 2002 Sep;3(9):705-14
references.pmid: 12209119
references.citation: Clin Ther. 2012 Dec;34(12):2268-78
references.pmid: 23200102
references.citation: J Neurosci. 2002 Apr 1;22(7):2451-9
references.pmid: 11923409
references.citation: Mult Scler. 2010 Apr;16(4):503-10
references.pmid: 20086020
references.citation: Ann Neurol. 2002 Feb;51(2):215-23
references.pmid: 11835378
references.citation: J Neurovirol. 2003 Feb;9(1):79-93
references.pmid: 12587071
references.citation: Nat Neurosci. 2011 Jan;14(1):45-53
references.pmid: 21131950
references.citation: Cell. 1991 Aug 23;66(4):807-15
references.pmid: 1715244
references.citation: Glia. 2006 Sep;54(4):297-303
references.pmid: 16856149
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18171-6
references.pmid: 16330757
references.citation: Cell Death Dis. 2012 Jun 28;3:e331
references.pmid: 22739983
references.citation: Exp Neurol. 2010 Nov;226(1):231-41
references.pmid: 20832403
references.citation: Neurosci Res. 2004 Dec;50(4):459-65
references.pmid: 15567483
references.citation: Brain. 2005 Mar;128(Pt 3):528-39
references.pmid: 15699059
references.citation: Br J Pharmacol. 2008 Jan;153(2):216-25
references.pmid: 17891163
references.citation: Brain Res. 2012 Dec 7;1488:92-103
references.pmid: 23031637
references.citation: Lancet Neurol. 2011 Jul;10(7):649-56
references.pmid: 21683930
references.citation: Nat Rev Immunol. 2008 Sep;8(9):726-36
references.pmid: 19172693
references.citation: Neuropathol Appl Neurobiol. 2008 Dec;34(6):577-89
references.pmid: 19076696
references.citation: Prog Brain Res. 2012;201:219-31
references.pmid: 23186717
references.citation: Neurology. 1996 Feb;46(2):538-45
references.pmid: 8614528
references.citation: Nat Neurosci. 2005 Jun;8(6):745-51
references.pmid: 15895088
references.citation: CNS Neurol Disord Drug Targets. 2008 Jun;7(3):313-20
references.pmid: 18673215
references.citation: J Neuroimmunol. 2004 Mar;148(1-2):116-26
references.pmid: 14975592
references.citation: Biochim Biophys Acta. 2011 Feb;1812(2):184-93
references.pmid: 20887785
references.citation: Ann N Y Acad Sci. 1984;436:11-32
references.pmid: 6598010